BRIEF-GSK, Theravance submit regulatory application for UMEC/VI in the U.S.

LONDON Tue Dec 18, 2012 7:08am EST

LONDON Dec 18 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for umec/vi (lama/laba) in

the US * Regulatory filings for umec/vi are planned in the EU imminently and in other

countries during the course of 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.